UNSPSC 41131719: Glycosylated hemoglobin assay

In this classification a glycosylated hemoglobin assay is a device used to measure the glycosylated hemoglobins (A1a, A1b, and A1c) in a patient's blood by a column chromatographic procedure. Measurement of glycosylated hemoglobin is used to assess the level of control of a patient's diabetes and to determine the proper insulin dosage for a patient. Elevated levels of glycosylated hemoglobin indicate uncontrolled diabetes in a patient US FDA regulates Glycosylated hemoglobin assay under 21 CFR 864.7470 and under FDA product code LCP.

UNSPSC 41131719 Glycosylated hemoglobin assay is a Commodity code that does not align with the recent state and local opportunities posted under this classification. The opportunities posted under 41131719 instead reflect broader drug testing and forensic laboratory services, including offender urinalysis and drug screening, occupational medical testing, laboratory supplies for toxicology and seized-drug analysis, and specialized assay kits for psychiatric monitoring — none of which center on hemoglobin A1c or glucose-metabolism testing. The mismatch suggests either a tagging error in the procurement database or a code applied at the issuing body level that does not reflect the true scope of work.

The recent opportunities span multiple issuing bodies including county corrections and criminal justice departments (Collin County, Texas), county health services (Collin County Health Care Services, Gwinnett County), state procurement divisions (Texas Comptroller of Public Accounts, State of Oregon), city government (City of Charlotte), county public health (Bernalillo County), and public universities (University of Wisconsin-Madison). The geographic distribution includes activity in Texas, Georgia, North Carolina, New Mexico, Florida, and Oregon. Representative recent solicitations include an RFP from Collin County Community Supervision and Corrections Department (posted September 25, 2026, due July 23, 2026) for offender specimen collection and drug testing services with an estimated contract value of $600,000 and annual testing demand of approximately 25,031 tests; an IFB from the Texas Comptroller of Public Accounts (posted September 23, 2026, due October 20, 2026) for proprietary chemical laboratory equipment and supplies including DNA analysis kits and drug-screening reagents serving the Texas Department of Public Safety and Parks and Wildlife; and an RFP from Benton County, Oregon (posted June 6, 2026, due July 7, 2026) for urinalysis testing services supporting the county's Family Treatment Court Program with CLIA-certified laboratory requirements and twice-weekly minimum testing.